Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	ABCG4 PMS2 ABCB10 LONP2 HLTF CCT6B CHD1L ATP2B1 ATP2B2 ATP2B3 ACSS3 ABCB1 DDX11	3.63e-06	614	90	13	GO:0140657
GeneOntologyMolecularFunction	ATP hydrolysis activity	ABCG4 PMS2 ABCB10 LONP2 CCT6B CHD1L ATP2B1 ATP2B2 ATP2B3 ABCB1 DDX11	4.67e-06	441	90	11	GO:0016887
GeneOntologyMolecularFunction	ATPase-coupled transmembrane transporter activity	ABCG4 ABCB10 ATP2B1 ATP2B2 ATP2B3 ABCB1	9.88e-06	109	90	6	GO:0042626
GeneOntologyMolecularFunction	P-type calcium transporter activity	ATP2B1 ATP2B2 ATP2B3	1.42e-05	11	90	3	GO:0005388
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	ABCG4 PMS2 ABCB10 LONP2 GNL2 HLTF CCT6B CHD1L ARL15 ATP2B1 ATP2B2 ATP2B3 ABCB1 DDX11	2.26e-05	840	90	14	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	ABCG4 PMS2 ABCB10 LONP2 GNL2 HLTF CCT6B CHD1L ARL15 ATP2B1 ATP2B2 ATP2B3 ABCB1 DDX11	2.26e-05	840	90	14	GO:0016818
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	ABCG4 PMS2 ABCB10 LONP2 GNL2 CCT6B CHD1L ARL15 ATP2B1 ATP2B2 ATP2B3 ABCB1 DDX11	4.27e-05	775	90	13	GO:0017111
GeneOntologyMolecularFunction	pyrophosphatase activity	ABCG4 PMS2 ABCB10 LONP2 GNL2 CCT6B CHD1L ARL15 ATP2B1 ATP2B2 ATP2B3 ABCB1 DDX11	9.55e-05	839	90	13	GO:0016462
GeneOntologyMolecularFunction	GPI anchor binding	DPEP1 PSG6 PSG11	1.47e-04	23	90	3	GO:0034235
GeneOntologyMolecularFunction	primary active transmembrane transporter activity	ABCG4 ABCB10 ATP2B1 ATP2B2 ATP2B3 ABCB1	1.55e-04	178	90	6	GO:0015399
GeneOntologyMolecularFunction	transmembrane transporter activity	ABCG4 NIPAL4 SLC26A8 ABCB10 PSG6 PSG11 TIMM17A SLC28A3 HCN2 SLC26A11 ATP2B1 ATP2B2 ATP2B3 SLC2A1 ABCB1	2.39e-04	1180	90	15	GO:0022857
GeneOntologyMolecularFunction	active transmembrane transporter activity	ABCG4 SLC26A8 ABCB10 SLC28A3 SLC26A11 ATP2B1 ATP2B2 ATP2B3 ABCB1	2.99e-04	477	90	9	GO:0022804
GeneOntologyMolecularFunction	lipid transmembrane transporter activity	ABCG4 PSG6 PSG11 SLC2A1	3.31e-04	73	90	4	GO:0170055
GeneOntologyMolecularFunction	P-type transmembrane transporter activity	ATP2B1 ATP2B2 ATP2B3	5.68e-04	36	90	3	GO:0140358
GeneOntologyMolecularFunction	P-type ion transporter activity	ATP2B1 ATP2B2 ATP2B3	5.68e-04	36	90	3	GO:0015662
GeneOntologyMolecularFunction	transporter activity	ABCG4 NIPAL4 SLC26A8 ABCB10 PSG6 PSG11 TIMM17A SLC28A3 HCN2 SLC26A11 ATP2B1 ATP2B2 ATP2B3 SLC2A1 ABCB1	6.10e-04	1289	90	15	GO:0005215
GeneOntologyMolecularFunction	secondary active sulfate transmembrane transporter activity	SLC26A8 SLC26A11	1.08e-03	11	90	2	GO:0008271
GeneOntologyMolecularFunction	extracellular matrix structural constituent conferring tensile strength	COL6A3 COL21A1 COL6A5	1.17e-03	46	90	3	GO:0030020
GeneOntologyMolecularFunction	ABC-type transporter activity	ABCG4 ABCB10 ABCB1	1.40e-03	49	90	3	GO:0140359
GeneOntologyMolecularFunction	glycolipid binding	DPEP1 PSG6 PSG11	1.40e-03	49	90	3	GO:0051861
GeneOntologyMolecularFunction	granulocyte colony-stimulating factor receptor binding	PSG6 PSG11	1.76e-03	14	90	2	GO:0005130
GeneOntologyMolecularFunction	pre-mRNA intronic binding	ELAVL4 PRPF8	1.76e-03	14	90	2	GO:0097157
GeneOntologyMolecularFunction	lipid transporter activity	ABCG4 PSG6 PSG11 SLC2A1 ABCB1	1.94e-03	196	90	5	GO:0005319
GeneOntologyMolecularFunction	organic anion transmembrane transporter activity	SLC26A8 PSG6 PSG11 SLC26A11 SLC2A1 ABCB1	2.11e-03	293	90	6	GO:0008514
GeneOntologyMolecularFunction	sulfate transmembrane transporter activity	SLC26A8 SLC26A11	2.31e-03	16	90	2	GO:0015116
GeneOntologyMolecularFunction	PDZ domain binding	HCN2 ATP2B1 ATP2B2 ATP2B3	2.33e-03	123	90	4	GO:0030165
GeneOntologyMolecularFunction	active monoatomic ion transmembrane transporter activity	SLC26A8 SLC28A3 SLC26A11 ATP2B1 ATP2B2 ATP2B3	2.41e-03	301	90	6	GO:0022853
GeneOntologyMolecularFunction	carboxylic acid transmembrane transporter activity	SLC26A8 PSG6 PSG11 SLC2A1 ABCB1	2.46e-03	207	90	5	GO:0046943
GeneOntologyMolecularFunction	organic acid transmembrane transporter activity	SLC26A8 PSG6 PSG11 SLC2A1 ABCB1	2.51e-03	208	90	5	GO:0005342
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	PMS2 HLTF CHD1L DDX11	2.62e-03	127	90	4	GO:0008094
GeneOntologyMolecularFunction	ATPase-coupled monoatomic cation transmembrane transporter activity	ATP2B1 ATP2B2 ATP2B3	2.76e-03	62	90	3	GO:0019829
GeneOntologyMolecularFunction	toxic substance binding	DSG1 AHR	2.93e-03	18	90	2	GO:0015643
GeneOntologyMolecularFunction	calmodulin binding	PSG6 PSG11 ATP2B1 ATP2B2 ATP2B3	3.86e-03	230	90	5	GO:0005516
GeneOntologyMolecularFunction	organic hydroxy compound transmembrane transporter activity	ABCG4 PSG6 PSG11	3.90e-03	70	90	3	GO:1901618
GeneOntologyBiologicalProcess	positive regulation of growth rate	RFTN1 GHRL AHR	3.20e-07	4	90	3	GO:0040010
GeneOntologyBiologicalProcess	regulation of growth rate	RFTN1 GHRL AHR	4.43e-06	8	90	3	GO:0040009
GeneOntologyBiologicalProcess	insulin catabolic process	PSG6 PSG11 CTSD	5.23e-05	17	90	3	GO:1901143
GeneOntologyBiologicalProcess	cellular response to cAMP	AHR CPS1 HCN2 KDM1A	8.43e-05	53	90	4	GO:0071320
GeneOntologyBiologicalProcess	negative regulation of response to tumor cell	PSG6 PSG11 AHR	1.01e-04	21	90	3	GO:0002835
GeneOntologyBiologicalProcess	negative regulation of immune response to tumor cell	PSG6 PSG11 AHR	1.01e-04	21	90	3	GO:0002838
GeneOntologyBiologicalProcess	granulocyte differentiation	FASN PSG6 PSG11 KDM1A	1.37e-04	60	90	4	GO:0030851
GeneOntologyBiologicalProcess	mRNA metabolic process	TRAF5 IGF2BP2 ZNF473 PAPOLA HLTF PUM2 ELAVL4 CCAR2 NR1H2 PRPF8 PUM1 BOLL HNRNPH3	1.68e-04	917	90	13	GO:0016071
GeneOntologyBiologicalProcess	fatty acid metabolic process	FASN LONP2 PSG6 SGPL1 PSG11 AOAH AHR NR1H2 CES2	1.83e-04	461	90	9	GO:0006631
GeneOntologyCellularComponent	apical plasma membrane	DPEP1 DSG1 PSG6 PSG11 PKHD1 SLC26A11 ATP2B1 ATP2B2 SLC2A1 ABCB1	5.61e-05	487	92	10	GO:0016324
GeneOntologyCellularComponent	apical part of cell	DPEP1 DSG1 PSG6 PSG11 PKHD1 SLC26A11 ATP2B1 ATP2B2 SLC2A1 ABCB1	2.76e-04	592	92	10	GO:0045177
Domain	ATP_Ca_trans_C	ATP2B1 ATP2B2 ATP2B3	4.61e-07	4	92	3	IPR022141
Domain	ATP_Ca_trans_C	ATP2B1 ATP2B2 ATP2B3	4.61e-07	4	92	3	PF12424
Domain	P-type_ATPase_IIB	ATP2B1 ATP2B2 ATP2B3	4.61e-07	4	92	3	IPR006408
Domain	Pumilio_RNA-bd	PUM2 PUM1	2.40e-05	2	92	2	IPR033712
Domain	ATPase_P-typ_TM_dom	ATP2B1 ATP2B2 ATP2B3	6.18e-05	16	92	3	IPR023298
Domain	-	ATP2B1 ATP2B2 ATP2B3	6.18e-05	16	92	3	1.20.1110.10
Domain	PUF	PUM2 PUM1	7.18e-05	3	92	2	PF00806
Domain	PUM_HD	PUM2 PUM1	7.18e-05	3	92	2	PS50303
Domain	PUM-HD	PUM2 PUM1	7.18e-05	3	92	2	IPR033133
Domain	ATPase_P-typ_cation-transptr_C	ATP2B1 ATP2B2 ATP2B3	7.48e-05	17	92	3	IPR006068
Domain	Cation_ATPase_C	ATP2B1 ATP2B2 ATP2B3	7.48e-05	17	92	3	PF00689
Domain	Cation_ATPase_N	ATP2B1 ATP2B2 ATP2B3	8.95e-05	18	92	3	PF00690
Domain	Cation_ATPase_N	ATP2B1 ATP2B2 ATP2B3	8.95e-05	18	92	3	SM00831
Domain	ATPase_P-typ_cation-transptr_N	ATP2B1 ATP2B2 ATP2B3	1.06e-04	19	92	3	IPR004014
Domain	PUM	PUM2 PUM1	1.43e-04	4	92	2	PS50302
Domain	Pumilio_RNA-bd_rpt	PUM2 PUM1	1.43e-04	4	92	2	IPR001313
Domain	Pumilio	PUM2 PUM1	1.43e-04	4	92	2	SM00025
Domain	VWA	COL6A3 ITGA11 COL21A1 COL6A5	1.66e-04	56	92	4	PF00092
Domain	Carboxylesterase_B_AS	BCHE CES2	6.59e-04	8	92	2	IPR019826
Domain	PH-BEACH_dom	WDFY3 WDFY4	6.59e-04	8	92	2	IPR023362
Domain	-	WDFY3 WDFY4	6.59e-04	8	92	2	2.30.29.40
Domain	PH_BEACH	WDFY3 WDFY4	6.59e-04	8	92	2	PS51783
Domain	CARBOXYLESTERASE_B_1	BCHE CES2	6.59e-04	8	92	2	PS00122
Domain	ATPase_P-typ_cyto_domN	ATP2B1 ATP2B2 ATP2B3	6.75e-04	35	92	3	IPR023299
Domain	VWFA	COL6A3 ITGA11 COL21A1 COL6A5	7.19e-04	82	92	4	PS50234
Domain	ATPase_P-typ_P_site	ATP2B1 ATP2B2 ATP2B3	7.34e-04	36	92	3	IPR018303
Domain	P_typ_ATPase	ATP2B1 ATP2B2 ATP2B3	7.34e-04	36	92	3	IPR001757
Domain	ATPASE_E1_E2	ATP2B1 ATP2B2 ATP2B3	7.34e-04	36	92	3	PS00154
Domain	VWA	COL6A3 ITGA11 COL21A1 COL6A5	7.87e-04	84	92	4	SM00327
Domain	ATPase_P-typ_transduc_dom_A	ATP2B1 ATP2B2 ATP2B3	7.96e-04	37	92	3	IPR008250
Domain	E1-E2_ATPase	ATP2B1 ATP2B2 ATP2B3	7.96e-04	37	92	3	PF00122
Domain	BEACH	WDFY3 WDFY4	8.45e-04	9	92	2	PS50197
Domain	Beach	WDFY3 WDFY4	8.45e-04	9	92	2	PF02138
Domain	-	WDFY3 WDFY4	8.45e-04	9	92	2	1.10.1540.10
Domain	Beach	WDFY3 WDFY4	8.45e-04	9	92	2	SM01026
Domain	BEACH_dom	WDFY3 WDFY4	8.45e-04	9	92	2	IPR000409
Domain	SLC26A	SLC26A8 SLC26A11	1.05e-03	10	92	2	PS01130
Domain	Hydrolase_3	ATP2B2 ATP2B3	1.05e-03	10	92	2	PF08282
Domain	ABC_transporter_CS	ABCG4 ABCB10 ABCB1	1.16e-03	42	92	3	IPR017871
Domain	STAS	SLC26A8 SLC26A11	1.28e-03	11	92	2	PS50801
Domain	STAS	SLC26A8 SLC26A11	1.28e-03	11	92	2	PF01740
Domain	SLC26A/SulP_fam	SLC26A8 SLC26A11	1.28e-03	11	92	2	IPR001902
Domain	STAS_dom	SLC26A8 SLC26A11	1.28e-03	11	92	2	IPR002645
Domain	SLC26A/SulP_dom	SLC26A8 SLC26A11	1.28e-03	11	92	2	IPR011547
Domain	-	SLC26A8 SLC26A11	1.28e-03	11	92	2	3.30.750.24
Domain	Sulfate_transp	SLC26A8 SLC26A11	1.28e-03	11	92	2	PF00916
Domain	VWF_A	COL6A3 ITGA11 COL21A1 COL6A5	1.45e-03	99	92	4	IPR002035
Domain	ABC_tran	ABCG4 ABCB10 ABCB1	1.70e-03	48	92	3	PF00005
Domain	ABC_TRANSPORTER_2	ABCG4 ABCB10 ABCB1	1.70e-03	48	92	3	PS50893
Domain	Carboxylesterase_B_CS	BCHE CES2	1.81e-03	13	92	2	IPR019819
Domain	ABC_TRANSPORTER_1	ABCG4 ABCB10 ABCB1	1.81e-03	49	92	3	PS00211
Domain	ABC_transporter-like	ABCG4 ABCB10 ABCB1	1.92e-03	50	92	3	IPR003439
Domain	CARBOXYLESTERASE_B_2	BCHE CES2	2.10e-03	14	92	2	PS00941
Domain	COesterase	BCHE CES2	2.10e-03	14	92	2	PF00135
Domain	CarbesteraseB	BCHE CES2	2.10e-03	14	92	2	IPR002018
Domain	-	UNC45B PUM2 WDFY3 PUM1 WDFY4	4.83e-03	222	92	5	1.25.10.10
Pathway	REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS	ATP2B1 ATP2B2 ATP2B3	3.07e-05	12	75	3	M27326
Pathway	WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION	ATP2B1 ATP2B2 ATP2B3 KDM1A	3.83e-05	36	75	4	M39831
Pathway	REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS	ATP2B1 ATP2B2 ATP2B3	5.05e-05	14	75	3	MM15052
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	FASN IGF2BP2 DSG1 TK1 SGPL1 HLTF CCT6B PDCD11 CCAR2 CHD1L WDFY3 PRPF8 PUM1 CTSD MVP ATP2B1 SLC2A1 KDM1A HNRNPH3	2.66e-09	1353	93	19	29467282
Pubmed	Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons.	ATP2B1 ATP2B2 ATP2B3	7.39e-08	4	93	3	12209837
Pubmed	Expression and role of calcium-ATPase pump and sodium-calcium exchanger in differentiated trophoblasts from human term placenta.	ATP2B1 ATP2B2 ATP2B3	7.39e-08	4	93	3	12784250
Pubmed	The plasma membrane calcium pump in health and disease.	ATP2B1 ATP2B2 ATP2B3	7.39e-08	4	93	3	23413890
Pubmed	Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes.	ATP2B1 ATP2B2 ATP2B3	7.39e-08	4	93	3	8245032
Pubmed	Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes.	ATP2B1 ATP2B2 ATP2B3	7.39e-08	4	93	3	7989379
Pubmed	Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps.	ATP2B1 ATP2B2 ATP2B3	7.39e-08	4	93	3	11152753
Pubmed	PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†.	ATP2B1 ATP2B2 ATP2B3	7.39e-08	4	93	3	36130203
Pubmed	Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse.	ATP2B1 ATP2B2 ATP2B3	7.39e-08	4	93	3	10434059
Pubmed	Calcium pumps of plasma membrane and cell interior.	ATP2B1 ATP2B2 ATP2B3	7.39e-08	4	93	3	15101689
Pubmed	Plasma membrane calcium ATPases as critical regulators of calcium homeostasis during neuronal cell function.	ATP2B1 ATP2B2 ATP2B3	7.39e-08	4	93	3	10577388
Pubmed	Structural organization, ion transport, and energy transduction of P-type ATPases.	ATP2B1 ATP2B2 ATP2B3	7.39e-08	4	93	3	8634322
Pubmed	Differential regulation of the apical plasma membrane Ca(2+) -ATPase by protein kinase A in parotid acinar cells.	ATP2B1 ATP2B2 ATP2B3	1.84e-07	5	93	3	17938178
Pubmed	Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange.	ATP2B1 ATP2B2 ATP2B3	3.68e-07	6	93	3	12767889
Pubmed	Gene knockout studies of Ca2+-transporting ATPases.	ATP2B1 ATP2B2 ATP2B3	1.03e-06	8	93	3	10951186
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	FASN PKHD1 PDCD11 PRPF8 ATP2B1 ATP2B2 ATP2B3	1.25e-06	202	93	7	24639526
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	FASN IGF2BP2 ABCB10 TK1 GNL2 HLTF PDCD11 PUM2 CCAR2 CHD1L PRPF8 PUM1 SLC2A1 KDM1A HNRNPH3	2.15e-06	1318	93	15	30463901
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	FASN IGF2BP2 DSG1 GNL2 PDCD11 CCAR2 PRPF8 PUM1 NNT ATP2B1 KDM1A HNRNPH3 ABCB1	3.41e-06	1024	93	13	24711643
Pubmed	Human Pumilio-2 is expressed in embryonic stem cells and germ cells and interacts with DAZ (Deleted in AZoospermia) and DAZ-like proteins.	PUM2 PUM1 BOLL	5.19e-06	13	93	3	12511597
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	FASN DSG1 GNL2 PDCD11 CCAR2 SSR1 PRPF8 PUM1 CTSD NNT ATP2B1 ATP2B3 SLC2A1 KDM1A HNRNPH3	5.54e-06	1425	93	15	30948266
Pubmed	WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.	MAGEB2 FASN IGF2BP2 TK1 SGPL1 GNL2 CCT6B PRPF8 MVP HNRNPH3	6.02e-06	615	93	10	31048545
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	COL6A3 MAGEB2 VKORC1L1 TIMM17A ELAVL4 PUM1 ATP2B1 MOCS1	6.14e-06	363	93	8	14691545
Pubmed	Epidermal stratification requires retromer-mediated desmoglein-1 recycling.	DSG1 SLC2A1	7.07e-06	2	93	2	36495876
Pubmed	Expression dynamics of drug resistance genes, multidrug resistance 1 (MDR1) and lung resistance protein (LRP) during the evolution of overt leukemia in myelodysplastic syndromes.	MVP ABCB1	7.07e-06	2	93	2	16566920
Pubmed	Substrate specificity of human cathepsin D using internally quenched fluorescent peptides derived from reactive site loop of kallistatin.	SERPINA4 CTSD	7.07e-06	2	93	2	11341921
Pubmed	Cloning and comparative sequence analysis of PUM1 and PUM2 genes, human members of the Pumilio family of RNA-binding proteins.	PUM2 PUM1	7.07e-06	2	93	2	12459267
Pubmed	Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins.	PUM2 PUM1	7.07e-06	2	93	2	29165587
Pubmed	PUMILIO-mediated translational control of somatic cell cycle program promotes folliculogenesis and contributes to ovarian cancer progression.	PUM2 PUM1	7.07e-06	2	93	2	35507203
Pubmed	Bespoke RNA recognition by Pumilios.	PUM2 PUM1	7.07e-06	2	93	2	26517885
Pubmed	Mouse Pum1 and Pum2 genes, members of the Pumilio family of RNA-binding proteins, show differential expression in fetal and adult hematopoietic stem cells and progenitors.	PUM2 PUM1	7.07e-06	2	93	2	12667987
Pubmed	Novel roles of kallistatin, a specific tissue kallikrein inhibitor, in vascular remodeling.	SERPINA4 CTSD	7.07e-06	2	93	2	11258665
Pubmed	Localization of two genes encoding plasma membrane Ca2+ ATPases isoforms 2 (ATP2B2) and 3 (ATP2B3) to human chromosomes 3p26-->p25 and Xq28, respectively.	ATP2B2 ATP2B3	7.07e-06	2	93	2	8187550
Pubmed	Increased MDR1 Transporter Expression in Human Brain Endothelial Cells Through Enhanced Histone Acetylation and Activation of Aryl Hydrocarbon Receptor Signaling.	AHR ABCB1	7.07e-06	2	93	2	30963442
Pubmed	Ghrelin promotes oral tumor cell proliferation by modifying GLUT1 expression.	GHRL SLC2A1	7.07e-06	2	93	2	26407611
Pubmed	A Quantitative and Predictive Model for RNA Binding by Human Pumilio Proteins.	PUM2 PUM1	7.07e-06	2	93	2	31078383
Pubmed	Principles of mRNA control by human PUM proteins elucidated from multimodal experiments and integrative data analysis.	PUM2 PUM1	7.07e-06	2	93	2	32753408
Pubmed	Effects of PUMILIO1 and PUMILIO2 knockdown on cardiomyogenic differentiation of human embryonic stem cells culture.	PUM2 PUM1	7.07e-06	2	93	2	32437472
Pubmed	Homocitrullination Is a Novel Histone H1 Epigenetic Mark Dependent on Aryl Hydrocarbon Receptor Recruitment of Carbamoyl Phosphate Synthase 1.	AHR CPS1	7.07e-06	2	93	2	26424795
Pubmed	TET1 contributes to allergic airway inflammation and regulates interferon and aryl hydrocarbon receptor signaling pathways in bronchial epithelial cells.	TET1 AHR	7.07e-06	2	93	2	31089182
Pubmed	Characterization of RNP Networks of PUM1 and PUM2 Post-Transcriptional Regulators in TCam-2 Cells, a Human Male Germ Cell Model.	PUM2 PUM1	7.07e-06	2	93	2	32316190
Pubmed	Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRP.	MVP ABCB1	7.07e-06	2	93	2	9029166
Pubmed	Insulin-like growth factor 2 mRNA binding protein 2 promotes aerobic glycolysis and cell proliferation in pancreatic ductal adenocarcinoma via stabilizing GLUT1 mRNA.	IGF2BP2 SLC2A1	7.07e-06	2	93	2	31089713
Pubmed	Pms2 deficiency results in increased mutation in the Hprt gene but not the Tk gene of Tk(+/-) transgenic mice.	PMS2 TK1	7.07e-06	2	93	2	12840110
Pubmed	Genome-wide comparison of human keratinocyte and squamous cell carcinoma responses to UVB irradiation: implications for skin and epithelial cancer.	PUM2 PUM1	7.07e-06	2	93	2	12771951
Pubmed	Alternate modes of cognate RNA recognition by human PUMILIO proteins.	PUM2 PUM1	7.07e-06	2	93	2	21397187
Pubmed	Preservation of transendothelial glucose transporter 1 and P-glycoprotein transporters in a cortical slice culture model of the blood-brain barrier.	SLC2A1 ABCB1	7.07e-06	2	93	2	20603190
Pubmed	Plasma butyrylcholinesterase regulates ghrelin to control aggression.	GHRL BCHE	7.07e-06	2	93	2	25646463
Pubmed	Interaction of the conserved meiotic regulators, BOULE (BOL) and PUMILIO-2 (PUM2).	PUM2 BOLL	7.07e-06	2	93	2	15806553
Pubmed	PUMILIO proteins promote colorectal cancer growth via suppressing p21.	PUM2 PUM1	7.07e-06	2	93	2	35338151
Pubmed	[Expression and significance of P-gp/mdr1 mRNA, MRP and LRP in non-Hodgkin's lymphoma].	MVP ABCB1	7.07e-06	2	93	2	19615260
Pubmed	Comparative analysis of mRNA targets for human PUF-family proteins suggests extensive interaction with the miRNA regulatory system.	PUM2 PUM1	7.07e-06	2	93	2	18776931
Pubmed	Prognostic significance of multidrug resistance gene 1 (MDR1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) mRNA expression in acute leukemia.	MVP ABCB1	7.07e-06	2	93	2	16614510
Pubmed	Insulin acutely decreases hepatic fatty acid synthase activity.	FASN PSG6 PSG11	8.23e-06	15	93	3	16054098
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	FASN IGF2BP2 GNL2 PDCD11 CCAR2 PRPF8 PUM1 MVP NNT KDM1A	1.01e-05	653	93	10	22586326
Pubmed	Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.	IGF2BP2 DSG1 HLTF CCAR2 PRPF8 NNT KDM1A HNRNPH3	1.03e-05	390	93	8	17643375
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	FASN DSG1 SGPL1 GNL2 HLTF PUM2 PRPF8 PUM1 SLC2A1 KDM1A	1.04e-05	655	93	10	35819319
Pubmed	The IL-2 receptor beta chain gene (Il-2rb) is closely linked to the Pdgfb locus on mouse chromosome 15.	PSG6 PSG11 AHR B4GALNT2	1.37e-05	54	93	4	8482578
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	IGF2BP2 TENM4 TET1 CHD1L WDFY3 ARL15 PUM1 ATP2B1 SLC2A1	1.40e-05	536	93	9	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	IGF2BP2 TENM4 TET1 CHD1L WDFY3 ARL15 PUM1 ATP2B1 SLC2A1	1.44e-05	538	93	9	10512203
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	DPEP1 COL6A3 FASN SERPINA4 PKHD1 ARL15 SLC26A11 CTSD MVP PLS1 ABCB1 DOP1B	1.72e-05	1016	93	12	19056867
Pubmed	Antagonistic and cooperative AGO2-PUM interactions in regulating mRNAs.	PUM2 PUM1	2.12e-05	3	93	2	30333515
Pubmed	Non-redundant roles in sister chromatid cohesion of the DNA helicase DDX11 and the SMC3 acetyl transferases ESCO1 and ESCO2.	ESCO2 DDX11	2.12e-05	3	93	2	31935221
Pubmed	A novel function of human Pumilio proteins in cytoplasmic sensing of viral infection.	PUM2 PUM1	2.12e-05	3	93	2	25340845
Pubmed	Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins.	PUM2 PUM1	2.12e-05	3	93	2	26724866
Pubmed	New invMED1 element cis-activates human multidrug-related MDR1 and MVP genes, involving the LRP130 protein.	MVP ABCB1	2.12e-05	3	93	2	15272088
Pubmed	Trafficking of presynaptic PMCA signaling complexes in mouse photoreceptors requires Cav1.4 α1 subunits.	ATP2B1 ATP2B2	2.12e-05	3	93	2	22183401
Pubmed	Protein kinase C phosphorylates the carboxyl terminus of the plasma membrane Ca(2+)-ATPase from human erythrocytes.	ATP2B1 ATP2B2	2.12e-05	3	93	2	1827443
Pubmed	ABCB1, ABCC1, and LRP gene expressions are altered by LDL, HDL, and serum deprivation in a human doxorubicin-resistant uterine sarcoma cell line.	MVP ABCB1	2.12e-05	3	93	2	25603048
Pubmed	Plasma membrane Ca2+ ATPase isoform 2b interacts preferentially with Na+/H+ exchanger regulatory factor 2 in apical plasma membranes.	ATP2B1 ATP2B2	2.12e-05	3	93	2	11786550
Pubmed	Human Pumilio proteins directly bind the CCR4-NOT deadenylase complex to regulate the transcriptome.	PUM2 PUM1	2.12e-05	3	93	2	33397688
Pubmed	NORAD: Defender of the Genome.	PUM2 PUM1	2.12e-05	3	93	2	27157388
Pubmed	Plasma Membrane Calcium ATPase-Neuroplastin Complexes Are Selectively Stabilized in GM1-Containing Lipid Rafts.	ATP2B1 ATP2B2	2.12e-05	3	93	2	34948386
Pubmed	A novel epigenetic marker, Ten-eleven translocation family member 2 (TET2), is identified in the intractable epileptic brain and regulates ATP binding cassette subfamily B member 1 (ABCB1) in the blood-brain barrier.	TET1 ABCB1	2.12e-05	3	93	2	35235761
Pubmed	Identification of chemoresistance-related cell-surface glycoproteins in leukemia cells and functional validation of candidate glycoproteins.	CTSD SLC2A1	2.12e-05	3	93	2	24467213
Pubmed	Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes.	MAGEB2 WIF1	2.12e-05	3	93	2	17012225
Pubmed	PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells.	PUM2 PUM1	2.12e-05	3	93	2	28232582
Pubmed	Concomitance of P-gp/LRP Expression with EGFR Mutations in Exons 19 and 21 in Non-Small Cell Lung Cancers.	MVP ABCB1	2.12e-05	3	93	2	26632382
Pubmed	The effect of TRAIL on the expression of multidrug resistant genes MDR1, LRP and GST-π in drug-resistant gastric cancer cell SGC7901/VCR.	MVP ABCB1	2.12e-05	3	93	2	23178631
Pubmed	COP9 signalosome component CSN-5 stabilizes PUF proteins FBF-1 and FBF-2 in Caenorhabditis elegans germline stem and progenitor cells.	PUM2 PUM1	2.12e-05	3	93	2	38427913
Pubmed	Pumilio facilitates miRNA regulation of the E2F3 oncogene.	PUM2 PUM1	2.12e-05	3	93	2	22345517
Pubmed	Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.	MAGEB2 FASN IGF2BP2 ABCB10 GNL2 SSR1 CPS1 PRPF8 ATP2B1 HNRNPH3	2.48e-05	725	93	10	27025967
Pubmed	The E3 ubiquitin ligase and RNA-binding protein ZNF598 orchestrates ribosome quality control of premature polyadenylated mRNAs.	FASN DSG1 CCAR2 SSR1 CLIP1 ATP2B1 KDM1A	2.52e-05	320	93	7	28685749
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	COL6A3 COL6A5 CHADL CTSD	2.69e-05	64	93	4	22261194
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RFTN1 FASN GHRL PKHD1 CCAR2 USPL1 PRPF8 ATP2B1 ATP2B2 ATP2B3 PLS1 SMURF2 ABCB1 DDX11	2.88e-05	1442	93	14	35575683
Pubmed	Global landscape of HIV-human protein complexes.	ABCB10 SGPL1 PUM2 CCAR2 CTSD ATP2B1 PLS1 HNRNPH3	3.21e-05	457	93	8	22190034
Pubmed	A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.	IGF2BP2 PDCD11 PUM2 ELAVL4 PRPF8 PUM1 BOLL	4.21e-05	347	93	7	16033648
Pubmed	Inhibitory interaction of the 14-3-3 proteins with ubiquitous (PMCA1) and tissue-specific (PMCA3) isoforms of the plasma membrane Ca2+ pump.	ATP2B1 ATP2B3	4.23e-05	4	93	2	18029012
Pubmed	Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia.	MVP ABCB1	4.23e-05	4	93	2	18200595
Pubmed	Chronic activation of liver X receptor induces beta-cell apoptosis through hyperactivation of lipogenesis: liver X receptor-mediated lipotoxicity in pancreatic beta-cells.	FASN NR1H2	4.23e-05	4	93	2	17369526
Pubmed	PSD95beta regulates plasma membrane Ca2+ pump localization at the photoreceptor synapse.	ATP2B1 ATP2B2	4.23e-05	4	93	2	19233278
Pubmed	Expression of the multidrug resistance protein MRP and the lung-resistance protein LRP in nasal NK/T cell lymphoma: further exploring the role of P53 and WT1 gene.	MVP ABCB1	4.23e-05	4	93	2	18972317
Pubmed	Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.	MVP ABCB1	4.23e-05	4	93	2	17875533
Pubmed	Acyloxyacyl hydrolase modulates depressive-like behaviors through aryl hydrocarbon receptor.	AOAH AHR	4.23e-05	4	93	2	31017816
Pubmed	Mammalian Pum1 and Pum2 Control Body Size via Translational Regulation of the Cell Cycle Inhibitor Cdkn1b.	PUM2 PUM1	4.23e-05	4	93	2	30811992
Pubmed	Human T-cell lymphotropic virus type I Tax activates lung resistance-related protein expression in leukemic clones established from an adult T-cell leukemia patient.	MVP ABCB1	4.23e-05	4	93	2	11937269
Pubmed	CCAR2 negatively regulates nuclear receptor LXRα by competing with SIRT1 deacetylase.	CCAR2 NR1H2	4.23e-05	4	93	2	25661920
Pubmed	Acyloxyacyl hydrolase regulates voiding activity.	AOAH AHR	4.23e-05	4	93	2	32003596
Pubmed	Target RNA motif and target mRNAs of the Quaking STAR protein.	PUM2 PUM1	4.23e-05	4	93	2	16041388
Pubmed	Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1.	MVP ABCB1	4.23e-05	4	93	2	18809583
Pubmed	Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).	MVP ABCB1	4.23e-05	4	93	2	11986944
Interaction	C17orf78 interactions	ATP2B1 ATP2B2 ATP2B3	1.97e-05	12	92	3	int:C17orf78
Interaction	MIR199A2 interactions	IGF2BP2 PDCD11 PUM2 PUM1 HNRNPH3	2.54e-05	76	92	5	int:MIR199A2
Interaction	LGR4 interactions	FASN ABCB10 PKHD1 PDCD11 PRPF8 ATP2B1 ATP2B2 ATP2B3	2.66e-05	262	92	8	int:LGR4
Interaction	HSD17B6 interactions	ATP2B1 ATP2B2 ATP2B3	4.03e-05	15	92	3	int:HSD17B6
Interaction	MIR199A1 interactions	IGF2BP2 PDCD11 PUM2 PUM1 HNRNPH3	4.13e-05	84	92	5	int:MIR199A1
Interaction	MIR17 interactions	IGF2BP2 PDCD11 PUM2 PUM1 HNRNPH3	4.37e-05	85	92	5	int:MIR17
Interaction	MIR92A2 interactions	IGF2BP2 PDCD11 PUM2 PUM1 HNRNPH3	5.75e-05	90	92	5	int:MIR92A2
Interaction	MIR214 interactions	IGF2BP2 PDCD11 PUM2 PUM1 HNRNPH3	6.73e-05	93	92	5	int:MIR214
Interaction	MIRLET7F1 interactions	IGF2BP2 PDCD11 PUM2 PUM1 HNRNPH3	7.08e-05	94	92	5	int:MIRLET7F1
Interaction	MIRLET7A2 interactions	IGF2BP2 PDCD11 PUM2 PUM1 HNRNPH3	7.83e-05	96	92	5	int:MIRLET7A2
Interaction	MIRLET7F2 interactions	IGF2BP2 PDCD11 PUM2 PUM1 HNRNPH3	8.22e-05	97	92	5	int:MIRLET7F2
Interaction	MIR128-2 interactions	IGF2BP2 PDCD11 PUM2 PUM1 HNRNPH3	9.06e-05	99	92	5	int:MIR128-2
Interaction	MIRLET7A3 interactions	IGF2BP2 PDCD11 PUM2 PUM1 HNRNPH3	1.04e-04	102	92	5	int:MIRLET7A3
Interaction	MIR7-1 interactions	IGF2BP2 PDCD11 PUM2 PUM1 HNRNPH3	1.09e-04	103	92	5	int:MIR7-1
Interaction	SUV39H1 interactions	ESCO2 FASN AHR CCAR2 NR1H2 WDFY3 KDM1A	1.10e-04	238	92	7	int:SUV39H1
Interaction	CFTR interactions	MAGEB2 FASN SERPINA4 IGF2BP2 ABCB10 DSG1 TK1 COL21A1 UNC45B SGPL1 CCAR2 SSR1 PUM1 SLC26A11 CTSD MVP ATP2B1 SEMA3E	1.10e-04	1480	92	18	int:CFTR
Interaction	MIRLET7E interactions	IGF2BP2 PDCD11 PUM2 PUM1 HNRNPH3	1.25e-04	106	92	5	int:MIRLET7E
Interaction	MIRLET7A1 interactions	IGF2BP2 PDCD11 PUM2 PUM1 HNRNPH3	1.37e-04	108	92	5	int:MIRLET7A1
Cytoband	10q21	ANK3 SGPL1 TET1	4.42e-06	16	93	3	10q21
GeneFamily	ATPases Ca2+ transporting	ATP2B1 ATP2B2 ATP2B3	3.50e-06	9	64	3	1209
GeneFamily	WD repeat domain containing\|BEACH domain containing	WDFY3 WDFY4	4.37e-04	9	64	2	1230
GeneFamily	Collagens	COL6A3 COL21A1 COL6A5	5.76e-04	46	64	3	490
GeneFamily	CD molecules\|V-set domain containing\|Pregnancy specific glycoproteins	PSG6 PSG11	6.65e-04	11	64	2	1315
GeneFamily	ATP binding cassette subfamily B	ABCB10 ABCB1	6.65e-04	11	64	2	806
GeneFamily	Cadherin related	FAT3 CDHR4	1.62e-03	17	64	2	24
GeneFamily	Beta 4-glycosyltransferases	B4GALNT2 B4GALT6	1.62e-03	17	64	2	425
GeneFamily	RNA binding motif containing	IGF2BP2 ELAVL4 BOLL HNRNPH3	6.86e-03	213	64	4	725
Coexpression	GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	RFTN1 COL6A3 ZNF473 HLTF AHR CCT6B PUM1 ABCB1	5.62e-07	199	93	8	M8381
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_1000	FAT3 TET1 WIF1 PKHD1 WDFY3 ARHGAP20 ATP2B1 BOLL SEMA3E	1.70e-06	256	92	9	gudmap_developingGonad_e14.5_ epididymis_1000_k4
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	BNC1 PMS2 TENM4 PAPOLA FAT3 TET1 WIF1 PKHD1 WDFY3 ARHGAP20 PUM1 ATP2B1 SMURF2 BOLL SEMA3E	1.71e-06	801	92	15	gudmap_developingGonad_e14.5_ epididymis_1000
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TK1 AOAH PKHD1 ELAVL4 B4GALT6 ABCB1	1.35e-06	166	93	6	bb8135119dc37fdbba476599a56d368f422688dc
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL21A1 FAT3 BCHE COL6A5 ARHGAP20 ACSS3	2.15e-06	180	93	6	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 COL21A1 FAT3 COL6A5 ARHGAP20 ACSS3	2.86e-06	189	93	6	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 COL21A1 FAT3 COL6A5 ARHGAP20 ACSS3	2.94e-06	190	93	6	841cd55861b43578d704418b9bc0af2e8b88323a
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 COL21A1 FAT3 COL6A5 ARHGAP20 ACSS3	3.13e-06	192	93	6	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 COL21A1 FAT3 COL6A5 ARHGAP20 ACSS3	3.13e-06	192	93	6	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 COL21A1 FAT3 COL6A5 ARHGAP20 ACSS3	3.13e-06	192	93	6	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 COL21A1 FAT3 COL6A5 ARHGAP20 ACSS3	3.13e-06	192	93	6	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 COL21A1 FAT3 COL6A5 ARHGAP20 ACSS3	3.22e-06	193	93	6	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 COL21A1 FAT3 COL6A5 ARHGAP20 ACSS3	3.32e-06	194	93	6	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A3 COL21A1 BCHE COL6A5 ARHGAP20 ATP2B1	3.96e-06	200	93	6	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 TK1 COL21A1 FAT3 AHR	1.17e-05	141	93	5	091b5b72811db5fca2314f4a79d467566920e257
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DPEP1 ABCG4 COL6A3 ITGA11 HCN2	2.29e-05	162	93	5	56f1789e69a6cb29956e46aba92b290847327c1f
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	COL6A3 TENM4 COL21A1 FAT3 ARHGAP20	2.57e-05	166	93	5	65dafed953b01a9830b54309af75c7a561e88336
ToppCell	facs-Large_Intestine-Proximal\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPEP1 CA13 B4GALNT2 ARHGAP20 ATP2B1	2.73e-05	168	93	5	23e0e1592d7400012d289adb10c7598285bae2e9
ToppCell	facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENM4 AOAH CA13 WDFY4 B4GALT6	2.73e-05	168	93	5	04e168fe1d6f5f9e3d3bf9d7c13e800e3594868a
ToppCell	facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPEP1 COL6A3 COL6A5 ARHGAP20 SEMA3E	3.40e-05	176	93	5	c0a084f7a8645262d61971f094689e02bf15b113
ToppCell	facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPEP1 COL6A3 COL6A5 ARHGAP20 SEMA3E	3.40e-05	176	93	5	cccf9201f6e2da7524b911a5961d3b227edab222
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-nan\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGF2BP2 B4GALNT2 BCHE ARHGAP20 ATP2B1	3.40e-05	176	93	5	1dd54bfaa58541de51e5a8328651d390833bd480
ToppCell	RV-11._Adipocyte\|World / Chamber and Cluster_Paper	FASN TENM4 VKORC1L1 ARHGAP20 ACSS3	3.50e-05	177	93	5	f0edf04930692418953e4f00a917257804ec0ffd
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL21A1 FAT3 BCHE COL6A5 ARHGAP20	3.79e-05	180	93	5	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL21A1 FAT3 BCHE COL6A5 ARHGAP20	3.89e-05	181	93	5	9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENM4 FAT3 PKHD1 ELAVL4 CPS1	4.21e-05	184	93	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENM4 FAT3 PKHD1 ELAVL4 CPS1	4.21e-05	184	93	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENM4 FAT3 PKHD1 ELAVL4 CPS1	4.21e-05	184	93	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	droplet-Limb_Muscle-nan-24m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 BCHE CHADL HCN2 SEMA3E	4.43e-05	186	93	5	adba5647a2feaba8e361dc1020d2f2dc4ce36b16
ToppCell	COVID_vent-Myeloid-Dendritic\|COVID_vent / Disease condition, Lineage, Cell class and subclass	MAGEB2 GHRL AHR WDFY4 ATP2B1	4.43e-05	186	93	5	63a5cdd3f60681762a218be32db84be8f29b88fd
ToppCell	COVID_vent-Myeloid-Dendritic-cDC\|COVID_vent / Disease condition, Lineage, Cell class and subclass	MAGEB2 GHRL AHR WDFY4 ATP2B1	4.43e-05	186	93	5	39457a7b43537f2c3e221f9375c95d4515424d7d
ToppCell	COPD-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	RFTN1 FASN ANK3 WIF1 AHR	4.54e-05	187	93	5	030af361f8bdcd0aff4ec1922702833325cf74d8
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 FAT3 COL6A5 ARHGAP20 ACSS3	4.78e-05	189	93	5	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	RFTN1 ITGA11 COL21A1 BCHE MOCS1	4.90e-05	190	93	5	10125091ad648163777b02e9f0d5e8d7f17d44a5
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 COL21A1 FAT3 COL6A5 ACSS3	5.02e-05	191	93	5	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A3 TENM4 COL21A1 FAT3 BCHE	5.15e-05	192	93	5	72881b280a415e65f87a80ca1369cbb0b722a0c4
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	COL6A3 COL21A1 FAT3 COL6A5 MOCS1	5.28e-05	193	93	5	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A3 TENM4 COL21A1 FAT3 ARHGAP20	5.41e-05	194	93	5	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL6A3 NIPAL4 CHADL CTSD MVP	5.54e-05	195	93	5	1e28617ca55e5f318a228357737b968dfac8cca0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RFTN1 COL6A3 ITGA11 COL21A1 FAT3	5.68e-05	196	93	5	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RFTN1 COL6A3 ITGA11 COL21A1 FAT3	5.68e-05	196	93	5	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENM4 ANK3 PUM1 MVP ABCB1	5.82e-05	197	93	5	5bc11aff92da2a0aca8473f997fe7a99f3cae75d
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL6A3 COL21A1 FAT3 COL6A5 ARHGAP20	5.96e-05	198	93	5	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A3 COL21A1 WIF1 COL6A5 SLC26A11	5.96e-05	198	93	5	0c4d2c68a42f8a9e964e2dd28092fe75f5216834
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A3 COL21A1 BCHE COL6A5 ARHGAP20	6.10e-05	199	93	5	c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9
ToppCell	10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ABCG4 COL6A3 TENM4 MOCS1 ACSS3	6.10e-05	199	93	5	6200618e029063486719479c41eaf31798bd13cf
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DPEP1 CTSD PLS1 CES2 ABCB1	6.10e-05	199	93	5	0181c13379f869be47804cdb11bbdabcd30b9b23
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL6A3 COL21A1 BCHE COL6A5 ARHGAP20	6.10e-05	199	93	5	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	18-Distal-Mesenchymal-Mesenchyme_RSPO2+\|Distal / Age, Tissue, Lineage and Cell class	COL6A3 COL21A1 FAT3 ARHGAP20 ATP2B1	6.10e-05	199	93	5	95403988caef322314f4ed15415ad1a9a987adc1
ToppCell	distal-mesenchymal-Alveolar_Fibroblast\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A3 COL21A1 BCHE COL6A5 ARHGAP20	6.10e-05	199	93	5	655d07cf9a2fd9b945a2ed4f824cba0297de72a8
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DPEP1 CTSD PLS1 CES2 ABCB1	6.10e-05	199	93	5	ee981046217e8759610eb58a670d98f32cd83abc
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A3 COL21A1 BCHE COL6A5 ARHGAP20	6.25e-05	200	93	5	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A3 COL21A1 BCHE COL6A5 ARHGAP20	6.25e-05	200	93	5	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL21A1 FAT3 COL6A5 ARHGAP20	1.37e-04	125	93	4	b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b
ToppCell	Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf\|Hippocampus / BrainAtlas - Mouse McCarroll V32	BNC1 NIPAL4 CA13 PLS1	1.69e-04	132	93	4	dc6edfa821a1cdc645668b0af5ba5ff80dee10bd
ToppCell	Hippocampus-Macroglia-OLIGODENDROCYTE-O2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	BNC1 NIPAL4 CA13 PLS1	1.69e-04	132	93	4	60ced08bda5efc95a6f116cd0c6d1a779d99ed38
ToppCell	Severe-B_intermediate-14\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ANK3 HLTF CCT6B CLIP1	2.23e-04	142	93	4	9c7d5783302974b883bd887f997d094eb5925ec2
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GHRL AOAH WIF1 WDFY4	2.42e-04	145	93	4	778655fffd73df101e656154a41b478a1b695116
ToppCell	MS-CD8-memory_CD4\|MS / Condition, Cell_class and T cell subcluster	ITGA11 PMS2 TET1 CCT6B	3.04e-04	154	93	4	aec893cf3e1cf90e18a9117183fc7a1f397425a9
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A3 COL21A1 FAT3 COL6A5	3.35e-04	158	93	4	e5636c0b608d68bd426a2b446ac508e4512e86a4
ToppCell	TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue-9\|TCGA-Colorectal / Sample_Type by Project: Shred V9	COL21A1 ELAVL4 BCHE SEMA3E	3.43e-04	159	93	4	f376bf6cd0ed374211edac3c384f3a78f0caef2a
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT3 PKHD1 COL6A5 CPS1	3.52e-04	160	93	4	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT3 PKHD1 COL6A5 CPS1	3.52e-04	160	93	4	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DPEP1 COL6A3 FAT3 ARHGAP20	3.60e-04	161	93	4	b19f82dd98a3064581793711bb70373f18abecd9
ToppCell	ICU-SEP-Myeloid-cDC1\|ICU-SEP / Disease, Lineage and Cell Type	ITGA11 TET1 CHD1L WDFY4	3.60e-04	161	93	4	9fb73909fc2ec99f96ca2eed1a053bce89de7d16
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BNC1 COL6A3 FASN ARHGAP20	3.60e-04	161	93	4	a006491c991e6a134be20ad75092a91f3b7c3c91
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FAT3 PKHD1 CPS1 ATP2B3	3.69e-04	162	93	4	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	facs-Large_Intestine-Proximal-24m-Epithelial-enterocyte_of_epithelium_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPEP1 CA13 B4GALNT2 ATP2B1	3.86e-04	164	93	4	2a00515d91ea03efcfc2a3d3c805dc2711867fcd
ToppCell	normal_Lung-Epithelial_cells-Undetermined\|normal_Lung / Location, Cell class and cell subclass	FASN ANK3 WIF1 CTSD	3.86e-04	164	93	4	fa2dae15b38cb8f9642dbf00549beec8ee19e9bb
ToppCell	COVID-19-lung-Mesothelial\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BNC1 AHR SLC28A3 BCHE	3.86e-04	164	93	4	83303e2ba52008391b8dc3fae8225ab5bcb20063
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b-Inhibitory_Gad1Gad2_Id2.Bcl11b_(Interneuron,_Neurogliaform2)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ZNF473 WIF1 CCT6B	3.89e-04	68	93	3	cfd75c373e10b3761666ccd445ba74755efeb95f
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ZNF473 WIF1 CCT6B	3.89e-04	68	93	3	c25fb921dc83eecdc337353894829ae6b5192353
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b-Inhibitory_Gad1Gad2_Id2.Bcl11b_(Interneuron,_Neurogliaform2)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ZNF473 WIF1 CCT6B	3.89e-04	68	93	3	712f5f4d3a1e0c0db1a340332876206b93bdac31
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ESCO2 TK1 AOAH WDFY4	4.04e-04	166	93	4	63dc58864268b4e7779e4c45155022556fc634f9
ToppCell	normal_Pleural_Fluid-Myeloid_cells-mo-Mac\|Myeloid_cells / Location, Cell class and cell subclass	SLC26A8 HCN2 PLS1 SLC2A1	4.04e-04	166	93	4	d16af6570806ed2880bd0efb5298932fd2a89cf5
ToppCell	LV-11._Adipocyte\|World / Chamber and Cluster_Paper	FASN TENM4 VKORC1L1 ARHGAP20	4.04e-04	166	93	4	7e5852891714465c6228c9f955fd511ec79d0e02
ToppCell	normal_Lung-Fibroblasts-Mesothelial_cells\|Fibroblasts / Location, Cell class and cell subclass	BNC1 B4GALNT2 SLC28A3 BOLL	4.13e-04	167	93	4	892a2dc83ab5de5a1016402f8e95d2aabf651326
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRAF5 WIF1 BCHE SEMA3E	4.23e-04	168	93	4	74d6dbf9295933acdee785af9b73a94377d15412
ToppCell	Sigmoid-Macrophage-Macrophage\|Macrophage / Region, Cell class and subclass	SGPL1 AOAH AHR CTSD	4.23e-04	168	93	4	bb16e135b6ae0d66615420b61edd6f62f2a3233c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RFTN1 COL6A3 COL6A5 ARHGAP20	4.23e-04	168	93	4	d19a115365c5415e51c039718d7669de788fcf33
ToppCell	droplet-Lung-nan-18m-Myeloid-dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESCO2 TK1 CCT6B WDFY4	4.23e-04	168	93	4	96f7411474edd673b8d3ee6b8a8bb185c246daaf
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL6A3 TENM4 FAT3 COL6A5	4.42e-04	170	93	4	ba4ba66b624089ed50a9083176386c7941b4c7a3
ToppCell	facs-Heart-RV-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 COL6A5 ARHGAP20 SEMA3E	4.42e-04	170	93	4	d7c9a604311974ff87ece43a0f8725a234d262f7
ToppCell	facs-Marrow-Granulocytes-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TK1 AOAH ATP2B2 B4GALT6	4.52e-04	171	93	4	dca4aa921896ec935fb7acdf25a62d8eba679602
ToppCell	facs-Marrow-Granulocytes-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TK1 AOAH ATP2B2 B4GALT6	4.52e-04	171	93	4	add2f7d34889ec654b8c71b4b1f084736111dc88
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Cilia-bearing_cell\|5w / Sample Type, Dataset, Time_group, and Cell type.	SGPL1 CHADL NNT PLS1	4.72e-04	173	93	4	d4cbeae262abfa30d8c5452285d3261a96875610
ToppCell	LV-11._Adipocyte\|LV / Chamber and Cluster_Paper	FASN TENM4 VKORC1L1 ARHGAP20	4.72e-04	173	93	4	c2d3fcb3de71015d03d14c63450853d2b03ffa71
ToppCell	droplet-Lung-nan-18m-Myeloid-Proliferating_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESCO2 TK1 CCT6B WDFY4	4.72e-04	173	93	4	20a20429aa898097d5ec4880ed64846558b5890f
ToppCell	3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 ITGA11 CHADL SEMA3E	4.72e-04	173	93	4	11e95a60b5f6f07f27154a23203bac431e7528c6
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Enterocyte\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPEP1 B4GALNT2 ATP2B1 PLS1	4.83e-04	174	93	4	2fbdb62e269acf4447b171700a615e878dde7f9f
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPEP1 B4GALNT2 ATP2B1 PLS1	4.83e-04	174	93	4	7c52b5d8f1e65e5208c952be341fa155ed0e6e76
ToppCell	Dendritic_Cells-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	GHRL TRBV11-2 AOAH ELAVL4	4.93e-04	175	93	4	584290a51f9975782a5ac8c6ad67c778d8323f8c
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DPEP1 COL6A3 FAT3 AHR	4.93e-04	175	93	4	282f09bbdfa70d93b3f66591dcfb84c5ee0268c7
ToppCell	normal_Lung-Fibroblasts-Mesothelial_cells\|normal_Lung / Location, Cell class and cell subclass	BNC1 SLC28A3 BCHE BOLL	5.04e-04	176	93	4	f31d7234053085a82cf9d55aeedd1e04d34789c3
ToppCell	COVID-19-kidney-Distal_Epi_Doublet_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	ANK3 PKHD1 SLC2A1 ABCB1	5.04e-04	176	93	4	36f77d878a53b30465b0dea8333a3865dba75613
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RFTN1 TRAF5 ELAVL4 WDFY4	5.15e-04	177	93	4	aa56129d2d5a73a10e33b7162233a4d9337ee535
ToppCell	356C-Fibroblasts-Fibroblast-G\|356C / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 COL21A1 BCHE COL6A5	5.15e-04	177	93	4	8220cc2fc0ee8764a67a3be51d75248be2453040
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-Migratory_DCs_L.1.2.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RFTN1 TRAF5 ELAVL4 WDFY4	5.15e-04	177	93	4	d78a6003ce2d15d7771ae385de252eec7e3c3eea
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic-Paneth\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DPEP1 SLC28A3 CPS1 PLS1	5.15e-04	177	93	4	2af09028014f4ec3b7d2a4c286f1ae5e84a9f590
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RFTN1 TRAF5 ELAVL4 WDFY4	5.15e-04	177	93	4	70ca5b6fde2e38af1eb88a7d6e8746edba298191
ToppCell	356C-Fibroblasts-Fibroblast-G-\|356C / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 COL21A1 BCHE COL6A5	5.15e-04	177	93	4	7617270f49cd6b7ba66db72d20560cee985012b2
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 ITGA11 DHRS7C SLC28A3	5.15e-04	177	93	4	b872ee91e01265b101b81bd304cf6b95d5419e68
ToppCell	RV-11._Adipocyte\|RV / Chamber and Cluster_Paper	FASN TENM4 VKORC1L1 ARHGAP20	5.26e-04	178	93	4	278bbea5cf8f0589f71675c7a3d00679391b5253
Drug	octaethylene glycol	BCHE ATP2B1 ATP2B2 ATP2B3 SLC2A1	1.06e-07	29	92	5	CID000078798
Drug	Ro 46861	ESCO2 ATP2B1 ATP2B2 ATP2B3	1.21e-07	12	92	4	CID000003128
Drug	NSC24559	ITGA11 SGPL1 MVP CLIP1 B4GALT6 CES2 ABCB1	6.41e-07	122	92	7	CID000029051
Drug	AC1L1IIA	COL6A3 BCHE NNT ATP2B1 ATP2B2 ATP2B3 ABCB1	6.34e-06	172	92	7	CID000004591
Drug	1sqc	ATP2B1 ATP2B2 ATP2B3	7.51e-06	10	92	3	CID000444279
Drug	Pyrethroids	BCHE ATP2B1 ATP2B2 ATP2B3 CES2	1.02e-05	71	92	5	CID000005053
Drug	2,5-dimethylquinone	ATP2B1 ATP2B2 ATP2B3	1.03e-05	11	92	3	CID000008718
Drug	cocaethylene	BCHE ATP2B1 ATP2B2 ATP2B3 CES2	1.17e-05	73	92	5	CID000002825
Drug	1vyq	ATP2B1 ATP2B2 ATP2B3	1.37e-05	12	92	3	CID004369390
Drug	dibromosalicyl	CTSD CES2	1.62e-05	2	92	2	CID000010662
Drug	8-hydroxycoumarin	ATP2B1 ATP2B2 ATP2B3	1.77e-05	13	92	3	CID000122783
Drug	C13932	COL6A3 B4GALNT2 CTSD ATP2B1 ATP2B2 ATP2B3 ABCB1	2.05e-05	206	92	7	CID000168297
Drug	benzoquinone	AHR BCHE CTSD ATP2B1 ATP2B2 ATP2B3 ABCB1	2.25e-05	209	92	7	CID000004650
Drug	p-hydroxyhippuric acid	ATP2B1 ATP2B2 ATP2B3	2.25e-05	14	92	3	CID000151012
Drug	C12E8	ATP2B1 ATP2B2 ATP2B3 SLC2A1	2.48e-05	42	92	4	CID000123921
Drug	linopirdine	ANK3 ATP2B1 ATP2B2 ATP2B3	2.73e-05	43	92	4	CID000003932
Drug	nimodipine	TK1 GNL2 ATP2B1 ATP2B2 ATP2B3 ABCB1	2.73e-05	145	92	6	CID000004497
Drug	agelasine B	TK1 ATP2B1 ATP2B2 ATP2B3	3.58e-05	46	92	4	CID006439899
Drug	AC1L88YH	ATP2B1 ATP2B2 ATP2B3	4.17e-05	17	92	3	CID000374551
Drug	indandione	BCHE CES2	4.83e-05	3	92	2	CID000123358
Drug	tripeptide tyroservatide	MVP ABCB1	4.83e-05	3	92	2	ctd:C510683
Drug	AC1Q2MLF	BCHE CES2	4.83e-05	3	92	2	CID002305233
Drug	AC1Q2IW1	BCHE CES2	4.83e-05	3	92	2	CID001713189
Drug	1-(2-bromoethyl)-1H-indole-2,3-dione	BCHE CES2	4.83e-05	3	92	2	CID003542734
Drug	6-bromo-5-methyl-1H-indole-2,3-dione	BCHE CES2	4.83e-05	3	92	2	CID001718647
Drug	AC1MBTQK	BCHE CES2	4.83e-05	3	92	2	CID002731127
Drug	7-Chloro-indoline-2,3-dione	BCHE CES2	4.83e-05	3	92	2	CID000344135
Drug	AC1MBVDR	BCHE CES2	4.83e-05	3	92	2	CID002731902
Drug	AC1MBVDX	BCHE CES2	4.83e-05	3	92	2	CID002731904
Drug	NSC-127077	BCHE CES2	4.83e-05	3	92	2	CID000277990
Drug	AC1MBV07	BCHE CES2	4.83e-05	3	92	2	CID002731733
Drug	AC1Q6FOF	BCHE CES2	4.83e-05	3	92	2	CID003114312
Drug	acetyl phosphate	BCHE ATP2B1 ATP2B2 ATP2B3 ACSS3	4.87e-05	98	92	5	CID000000186
Drug	carbonyl cyanide	SLC26A11 ATP2B1 ATP2B2 SLC2A1	4.99e-05	50	92	4	CID000517957
Drug	Permethrin	ABCG4 FASN AHR BCHE PRPF8 ATP2B3 CES2	5.42e-05	240	92	7	ctd:D026023
Drug	FCCP	NNT ATP2B1 ATP2B2 ATP2B3 SLC2A1	5.63e-05	101	92	5	CID000003330
Drug	NSC 298223	TK1 PSG6 NR1H2	5.90e-05	19	92	3	CID000073240
Drug	tetrofosmin	TET1 MVP ABCB1	5.90e-05	19	92	3	CID000004274
Drug	butyrate	FASN PSG6 BCHE MVP ATP2B1 ATP2B2 ATP2B3 SLC2A1 KDM1A CES2 ACSS3 ABCB1	6.02e-05	767	92	12	CID000000264
Drug	methylparaben	PLS1 BOLL CES2	6.92e-05	20	92	3	CID000007456
Drug	2brh	ATP2B1 ATP2B2 ATP2B3	8.06e-05	21	92	3	CID000848641
Drug	AC1L1JAO	BCHE ATP2B1 ATP2B2 ATP2B3	8.37e-05	57	92	4	CID000004955
Drug	AC1NSKPI	ATP2B1 ATP2B2 ATP2B3 ABCB1	8.37e-05	57	92	4	CID005311482
Drug	2-deoxyguanosine	PMS2 DSG1 TK1 PSG11 AHR NR1H2	8.58e-05	178	92	6	CID000000638
Drug	naringenin	AHR BCHE CTSD SLC2A1 ABCB1	8.83e-05	111	92	5	ctd:C005273
Drug	toxaphene	BCHE ATP2B1 ATP2B2 ATP2B3	8.96e-05	58	92	4	CID005284469
Drug	XM321	CTSD ABCB1	9.64e-05	4	92	2	CID000462242
Drug	AC1LD65L	BNC1 BCHE	9.64e-05	4	92	2	CID000612743
Drug	Xanthenes	AHR ABCB1	9.64e-05	4	92	2	ctd:D014966
Drug	5,6-dinitroacenaphthoquinone	BCHE CES2	9.64e-05	4	92	2	CID003477013
Drug	in1411	BCHE CES2	9.64e-05	4	92	2	CID001901244
Drug	SN-38 carboxylate form	CES2 ABCB1	9.64e-05	4	92	2	CID000443148
Drug	sanguinarine	AHR ATP2B1 ATP2B2 ATP2B3	1.02e-04	60	92	4	CID000005154
Drug	sodium	ANK3 AHR CA13 SLC28A3 BCHE HCN2 PRPF8 SLC26A11 ATP2B1 ATP2B2 ATP2B3 SMURF2 SLC2A1	1.06e-04	944	92	13	CID000000923
Drug	AC1L25Y6	ATP2B1 ATP2B2 ATP2B3	1.07e-04	23	92	3	CID000015465
Drug	butyrylthiocholine	BNC1 BCHE CES2	1.07e-04	23	92	3	CID000020689
Drug	lanthanum chloride hydrate	ATP2B1 ATP2B2 ATP2B3	1.07e-04	23	92	3	CID000165791
Drug	azinphos-methyl	BCHE BOLL CES2	1.22e-04	24	92	3	CID000002268
Drug	Digitoxigenin [143-62-4]; Down 200; 10.6uM; PC3; HT_HG-U133A	TRAF5 ANK3 ZNF473 WDFY3 ARL15 B4GALT6	1.26e-04	191	92	6	4217_DN
Drug	saligenin	BCHE CES2 SHKBP1	1.38e-04	25	92	3	CID000005146
Drug	cyhexatin	ATP2B1 ATP2B2 ATP2B3	1.38e-04	25	92	3	CID005364545
Drug	fluo-3	B4GALNT2 ATP2B1 ATP2B2 ATP2B3 ABCB1	1.38e-04	122	92	5	CID000104978
Drug	Diflunisal [22494-42-4]; Up 200; 16uM; MCF7; HT_HG-U133A	ZNF473 PAPOLA CHD1L MVP NNT SLC2A1	1.41e-04	195	92	6	4794_UP
Drug	Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A	RFTN1 ZNF473 NR1H2 USPL1 MVP CES2	1.45e-04	196	92	6	4997_DN
Drug	M EG	PMS2 SGPL1 ATP2B1 ATP2B2	1.49e-04	66	92	4	CID000004070
Drug	Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A	PMS2 ZNF473 PAPOLA MVP B4GALT6 CES2	1.50e-04	197	92	6	4988_DN
Drug	Ribostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; MCF7; HT_HG-U133A	RFTN1 IPP TIMM17A ARL15 NNT CES2	1.50e-04	197	92	6	3444_DN
Drug	Tropicamide [1508-75-4]; Down 200; 14uM; MCF7; HT_HG-U133A	RFTN1 MAGEB2 CCT6B WDFY3 NNT MOCS1	1.50e-04	197	92	6	2309_DN
Drug	carbonyl cyanide m-chlorophenylhydrazone	CPS1 NNT ATP2B1 ATP2B2 ATP2B3	1.55e-04	125	92	5	CID000002603
Drug	dodecyl ether	ATP2B1 ATP2B2 ATP2B3	1.55e-04	26	92	3	CID000020667
Drug	Schiff's reagent	FASN BCHE CES2	1.55e-04	26	92	3	CID000010484
Drug	2-methyl-1-propenol	BCHE CES2	1.60e-04	5	92	2	CID000123540
Drug	dimethylphosphinate	BCHE CTSD	1.60e-04	5	92	2	CID000076777
Drug	carpronium	BCHE HNRNPH3	1.60e-04	5	92	2	CID000002582
Drug	Cyclosporins	MVP ABCB1	1.60e-04	5	92	2	ctd:D003524
Drug	mercurybenzoate	BCHE CES2	1.60e-04	5	92	2	CID000011407
Drug	tallimustine	PMS2 PSG6 NR1H2	1.74e-04	27	92	3	CID000065924
Drug	dFdCTP	TK1 NR1H2 ABCB1	1.74e-04	27	92	3	CID000130659
Drug	tBuBHQ	B4GALNT2 ATP2B1 ATP2B2 ATP2B3	1.77e-04	69	92	4	CID000002374
Drug	L-beta-aspartyl phosphate	BCHE ATP2B1 ATP2B2 ATP2B3	1.77e-04	69	92	4	CID000000832
Drug	caged ATP	CHD1L ATP2B1 ATP2B2 ATP2B3	1.87e-04	70	92	4	CID000123806
Drug	alachlor	TK1 SGPL1 BCHE ABCB1	1.97e-04	71	92	4	CID000002078
Drug	pirimiphos-methyl	BCHE CTSD CES2	2.16e-04	29	92	3	CID000034526
Drug	AC1Q5O3Q	MVP CES2 ABCB1	2.16e-04	29	92	3	CID000368335
Drug	O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate	ANK3 TIMM17A BCHE ATP2B2 CES2 ABCB1	2.17e-04	211	92	6	ctd:C009618
Drug	Isoproterenol	DPEP1 IGF2BP2 GHRL TK1 DHRS7C AHR CPS1 ARHGAP20 CTSD CLIP1 SMURF2 SLC2A1 HNRNPH3	2.19e-04	1016	92	13	ctd:D007545
Drug	carbofuran	SGPL1 BCHE SSR1	2.40e-04	30	92	3	CID000002566
Drug	O,O,S-triethyl phosphorothioate	BCHE CES2	2.40e-04	6	92	2	CID000014459
Drug	vinyl 8-phenyloctanoate	BCHE CES2	2.40e-04	6	92	2	CID000194161
Drug	isosafrole	AHR ABCB1	2.40e-04	6	92	2	ctd:C015959
Drug	Phosphoryl	TK1 BCHE CHD1L ATP2B1 ATP2B2 ATP2B3	2.40e-04	215	92	6	CID006857426
Drug	D-triiodothyronine	COL6A3 FASN GHRL AHR ATP2B1 ATP2B2 ATP2B3 SLC2A1	2.53e-04	409	92	8	CID000000861
Drug	DL-penicillamine	DPEP1 COL6A3 DSG1 COL21A1 WDFY3	2.53e-04	139	92	5	CID000004727
Drug	tribufos	BCHE BOLL CES2	2.64e-04	31	92	3	CID000005125
Disease	Hailey-Hailey disease (implicated_via_orthology)	ATP2B1 ATP2B2 ATP2B3	5.64e-07	6	91	3	DOID:0050429 (implicated_via_orthology)
Disease	type 2 diabetes mellitus (is_implicated_in)	IGF2BP2 GHRL BCHE NR1H2 SLC2A1 ABCB1	1.54e-05	171	91	6	DOID:9352 (is_implicated_in)
Disease	Chediak-Higashi syndrome (implicated_via_orthology)	WDFY3 WDFY4	5.62e-05	4	91	2	DOID:2935 (implicated_via_orthology)
Disease	Colorectal Carcinoma	DPEP1 PMS2 ABCB10 TK1 WIF1 PKHD1 IPP B4GALNT2 BOLL ABCB1	6.19e-05	702	91	10	C0009402
Disease	nicotine dependence symptom count, depressive symptom measurement	ITGA11 IGF2BP2 UNC45B GNL2	8.70e-05	75	91	4	EFO_0007006, EFO_0009262
Disease	nephroblastoma (is_marker_for)	WIF1 SLC2A1 ABCB1	1.58e-04	34	91	3	DOID:2154 (is_marker_for)
Disease	Degenerative polyarthritis	DPEP1 CTSD MVP SLC2A1	2.00e-04	93	91	4	C0029408
Disease	Osteoarthrosis Deformans	DPEP1 CTSD MVP SLC2A1	2.00e-04	93	91	4	C0086743
Disease	Colorectal Neoplasms	ABCB10 TK1 WIF1 IPP BOLL ABCB1	2.22e-04	277	91	6	C0009404
Disease	Kidney Neoplasm	ESCO2 HLTF ABCB1	2.58e-04	40	91	3	C0022665
Disease	obstructive sleep apnea (biomarker_via_orthology)	GHRL ABCB1	2.60e-04	8	91	2	DOID:0050848 (biomarker_via_orthology)
Disease	Psychotic Disorders	TENM4 ANK3 TET1 ABCB1	2.75e-04	101	91	4	C0033975
Disease	Todd Paralysis	UNC45B BCHE	3.34e-04	9	91	2	C0234544
Disease	Paralysed	UNC45B BCHE	3.34e-04	9	91	2	C0522224
Disease	epilepsy (is_implicated_in)	BCHE ABCB1	3.34e-04	9	91	2	DOID:1826 (is_implicated_in)
Disease	Malignant neoplasm of kidney	ESCO2 HLTF ABCB1	3.67e-04	45	91	3	C0740457
Disease	Metabolic Diseases	DSG1 AHR	4.17e-04	10	91	2	C0025517
Disease	Bone Resorption	GHRL AHR	4.17e-04	10	91	2	C0005974
Disease	Cocaine-Related Disorders	GHRL COL21A1 BCHE CES2	4.81e-04	117	91	4	C0236736
Disease	serum albumin measurement	DPEP1 ABCG4 SERPINA4 IGF2BP2 SLC28A3 BCHE ARL15 CDHR4	4.94e-04	592	91	8	EFO_0004535
Disease	smoking status measurement, forced expiratory volume	PSG11 PKHD1	5.08e-04	11	91	2	EFO_0004314, EFO_0006527
Disease	Cleft palate, tobacco smoke exposure measurement, cleft lip, parental genotype effect measurement	ANK3 SHKBP1	5.08e-04	11	91	2	EFO_0003959, EFO_0005939, EFO_0009115, HP_0000175
Disease	Parkinson Disease, Secondary Vascular	BCHE ABCB1	6.08e-04	12	91	2	C0751414
Disease	Atherosclerotic Parkinsonism	BCHE ABCB1	6.08e-04	12	91	2	C0751415
Disease	Secondary Parkinson Disease	BCHE ABCB1	6.08e-04	12	91	2	C0030569
Disease	Cocaine Abuse	GHRL COL21A1 BCHE CES2	6.55e-04	127	91	4	C0009171
Disease	plasma beta-amyloid 1-42 measurement	ANK3 ACSS3	7.18e-04	13	91	2	EFO_0005660
Disease	biological sex	ANK3 FAT3 PKHD1 SLC28A3 CLIP1	7.43e-04	230	91	5	PATO_0000047
Disease	prefrontal cortex growth measurement	TENM4 ARL15	8.36e-04	14	91	2	EFO_0009334
Disease	macrophage inflammatory protein 1b measurement	DPEP1 ANK3 UNC45B CCT6B	8.46e-04	136	91	4	EFO_0008219
Disease	Cocaine Dependence	GHRL COL21A1 BCHE CES2	9.18e-04	139	91	4	C0600427
Disease	bipolar I disorder	TDRD15 TENM4 ANK3 ATP2B2	9.68e-04	141	91	4	EFO_0009963
Disease	Liver carcinoma	FASN SERPINA4 TK1 NR1H2 CTSD SLC2A1 ABCB1	9.91e-04	507	91	7	C2239176
Disease	body mass index, type 2 diabetes mellitus	IGF2BP2 ARL15	1.10e-03	16	91	2	EFO_0004340, MONDO_0005148
Disease	pulse pressure measurement	TDRD15 COL6A3 FASN TENM4 COL21A1 FAT3 TET1 IPP ARL15 NNT ATP2B1 KDM1A	1.16e-03	1392	91	12	EFO_0005763
Disease	Benign Neoplasm	FASN AHR ABCB1	1.23e-03	68	91	3	C0086692
Disease	Neoplasms	FASN AHR ABCB1	1.23e-03	68	91	3	C0027651
Disease	Nonorganic psychosis	TENM4 ANK3 TET1	1.28e-03	69	91	3	C0349204
Disease	Tachycardia	AHR BCHE	1.39e-03	18	91	2	C0039231
Disease	Tachyarrhythmia	AHR BCHE	1.39e-03	18	91	2	C0080203
Disease	body mass index, high density lipoprotein cholesterol measurement	ARL15 CLIP1	1.55e-03	19	91	2	EFO_0004340, EFO_0004612
Disease	Esophageal Neoplasms	GHRL WIF1 ABCB1	1.83e-03	78	91	3	C0014859
Disease	Malignant neoplasm of esophagus	GHRL WIF1 ABCB1	1.83e-03	78	91	3	C0546837
Disease	Drug toxicity	BCHE CES2 ABCB1	2.26e-03	84	91	3	C0013221
Disease	Adverse reaction to drug	BCHE CES2 ABCB1	2.26e-03	84	91	3	C0041755
Disease	urinary albumin to creatinine ratio	DPEP1 AHR CPS1 ARL15	2.32e-03	179	91	4	EFO_0007778
Disease	lateral orbital frontal cortex volume measurement	RFTN1 ACSS3	2.48e-03	24	91	2	EFO_0010312
Disease	Ataxia	PUM1 SLC2A1	2.69e-03	25	91	2	C0004134
Disease	Colitis	GHRL AHR	2.69e-03	25	91	2	C0009319
Disease	obesity (is_implicated_in)	GHRL NR1H2 SLC2A1	2.83e-03	91	91	3	DOID:9970 (is_implicated_in)
Disease	obsolete_red blood cell distribution width	IGF2BP2 TK1 SGPL1 AOAH CPS1 ARL15 ATP2B3 PLS1 SLC2A1 BOLL ABCB1	2.87e-03	1347	91	11	EFO_0005192
Disease	hair colour measurement	BNC1 DPEP1 TENM4 PKHD1 PUM2 ARL15 DDX11	2.95e-03	615	91	7	EFO_0007822

Protein segments in the cluster

Peptide	Gene	Start	Entry
VLPGQQAFLNKFQNG	AHR	791	P35869
GQKQGILGAQPQLIF	CCAR2	136	Q8N163
QGQCIFKGVVTNLIP	ABCG4	276	Q9H172
VQKNIAAFGGNPKSV	BCHE	206	P06276
VPFQNAILNVKELGG	ARL15	71	Q9NXU5
VGGSVLGNVFQFKLL	B4GALNT2	426	Q8NHY0
IPNRIFVGGIDFKTN	BOLL	31	Q8N9W6
NIGQNGVLFPNLKTV	BNC1	471	Q01954
IRNFPQGFNTVVGEK	ABCB10	616	Q9NRK6
LFGPFGAVNNVKVIR	ELAVL4	321	P26378
GVFLQIGEPNSQLQK	CA13	146	Q8N1Q1
APSQGLLGQAQKVFQ	CDHR4	191	A6H8M9
TFVVQIIIVQFGGKP	ATP2B1	1016	P20020
AIQIVIVQFGGKPFS	ATP2B2	1041	Q01814
IQIVIVQFGGKPFSC	ATP2B3	1016	Q16720
AASQGLKFVGVIPQY	RFTN1	151	Q14699
KGQIDPLNCIGIFQF	IPP	131	Q9Y573
VQPQSLQFIIDAFKG	PUM2	861	Q8TB72
NGGLQPAFAIIFSKI	ABCB1	721	P08183
GKENPFNPQIKQVFG	AOAH	556	P28039
KPGQKDVNGIAQFFL	OVOS1	116	Q6IE37
QNFGKINVVPQFSGD	GNL2	531	Q13823
INGLKTVGVNNPVFL	LONP2	426	Q86WA8
SVVFGLELNKVNPNG	MAGEB2	161	O15479
FGYNTGVINAPQKVI	SLC2A1	26	P11166
GQSFYGKLQTQVPNV	DOP1B	1291	Q9Y3R5
PQGQKGKVVFFANQI	DDX58	286	O95786
VVSGNPKLNLAFVAN	PLS1	356	Q14651
ANAGVQTFLGIPFAK	CES2	51	O00748
EIVQFFQGLEIVPNG	HNRNPH3	31	P31942
QILPGAVGFVAQLNV	GDPGP1	86	Q6ZNW5
NLFIPTQAVGAIIGK	IGF2BP2	431	Q9Y6M1
KFYIGPGQIQVGVVQ	ITGA11	191	Q9UKX5
FVAVLGGNIKQNPNT	DDX11	451	Q96FC9
GTFQRKPFGAILNLV	TK1	126	P04183
PYGIFVINQKTGEIN	DSG1	96	Q02413
KSFFLQPGEQLEQGI	MVP	306	Q14764
AFKIPGFQGQISFIT	MOCS1	291	Q9NZB8
VQPQSLQFIIDAFKG	PUM1	981	Q14671
PQSVIENVGGKIFTF	PAPOLA	86	P51003
ISGPFNVQFLVKGND	CPS1	1236	P31327
SGPQQTQKVFLFIRN	KDM1A	201	O60341
GLTVEQFRKINGFPN	B4GALT6	271	Q9UBX8
FNAPFDVGIKLSGVQ	GHRL	76	Q9UBU3
RQVFGEATKQPGITF	CTSD	176	P07339
FQFIGGSLQIGKALQ	COL6A5	101	A8TX70
IKNFGQQPIFVFLLS	CHD1L	406	Q86WJ1
SNLKQSGVVPFIFQA	COL6A3	961	P12111
NPQNFFAINIKTGLI	FAT3	1191	Q8TDW7
NFDIGPKFIQVGVVQ	COL21A1	66	Q96P44
GNLAPLTKGGQQLVF	ANK3	1371	Q12955
PQVTLQGGAAFFVRK	ESCO2	201	Q56NI9
TGQIVLVNNIQGKFG	DHRS7C	171	A6NNS2
LVNNIQGKFGIPFRT	DHRS7C	176	A6NNS2
KLAQIEGVVPFGANN	HLTF	126	Q14527
GNLLKVIPAAAFQGV	CHADL	71	Q6NUI6
GGINVLLKPNTSVQF	FASN	186	P49327
TNIPKLRAGFVGGQF	DPEP1	66	P16444
NGKFQLSGQKLFIPQ	PSG11	276	Q9UQ72
QFGALLQPGVNKFSL	HCN2	166	Q9UL51
VNGNKPGFIQFLGET	CLIP1	66	P30622
PAGVQNLVKQGFNVV	NNT	76	Q13423
FLNQKGPLTKGIFRQ	ARHGAP20	386	Q9P2F6
NKGFVVINQKGIDPF	CCT6B	286	Q92526
PANNIVKFLVGFTNK	SSR1	96	P43307
VVFGIFANILPVGEK	TDRD15	121	B5MCY1
FQLSGQKLFIPQITT	PSG6	371	Q00889
FLGSQKNVSPGFIKI	SLC26A8	836	Q96RN1
KGDATVFFILPNQGK	SERPINA4	271	P29622
IVDFAKQVPGFLQLG	NR1H2	281	P55055
LGVPVEALFFVGNQL	SHKBP1	286	Q8TBC3
PSQVQLKGVQFQVLG	PKHD1	2196	P08F94
GGPKFVNGVQQYISI	SLC28A3	536	Q9HAS3
NIKGIFVFGNPQLSV	SGPL1	436	O95470
AQLFGKNGSFLPNIQ	TRAF5	296	O00463
LKGRSNVLVFQQPGF	TET1	816	Q8NFU7
NIGPVAAFRNAVFVK	ACSS3	626	Q9H6R3
GNLTTKPINGAIFIF	PRPF8	1796	Q6P2Q9
AQFLALQKGFNEVIP	SMURF2	596	Q9HAU4
AQVQKVTPFGLTLNF	PDCD11	286	Q14690
LNAIQTVSGILQGPF	UNC45B	396	Q8IWX7
LQPSVKGVNNFGGFK	USPL1	786	Q5W0Q7
GFINNFGQIPKQLFK	WDFY3	2956	Q8IZQ1
IEIVPGKVFVGNFSQ	STYXL1	161	Q9Y6J8
KQGVALAFVGLQVPV	SLC26A11	541	Q86WA9
GPKLLIQFQNNGVVD	TRBV11-2	61	A0A584
GFVSNFGQVPKQLFT	WDFY4	2801	Q6ZS81
LVGVNISFVNNPLFG	TENM4	936	Q6N022
GNTILQTPQNAIFFK	WIF1	161	Q9Y5W5
IFGKDGVLNQPNSVF	VKORC1L1	76	Q8N0U8
GITIKNFFQGLPVVR	NIPAL4	246	Q0D2K0
FGQKQLQSLIPFVQL	PMS2	231	P54278
FQAIKGFRNSPVGVN	TIMM17A	31	Q99595
KNPVIFGLFNTTSNI	SEMA3E	321	O15041
NAGIQQAFQLPKLGA	ZBED1	296	O96006
KQGFFVSGKILDQNP	ZNF473	541	Q8WTR7